Počet záznamov: 1
vindesín
SYS d014751 LBL 00000nx--j22000003--45-- 005 20240119201232.9 100 $a 19920424csloy0103----ba0 152 $b mesh 250 $a vindesín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 86 $8 eng 300 1-
$a Vinblastine/analogs & derivatives (1980-1985) $8 eng 300 1-
$a Vinca Alkaloids (1973-1979) $8 eng 330 1-
$a Vinblastine derivative with antineoplastic activity against CANCER. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols (ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS). $8 eng 550 $3 sllk_un_auth*d000972 $Y Antineoplastic Agents, Phytogenic $5 P $a antineoplastiká fytogénne 550 $3 sllk_un_auth*d050257 $Y Tubulin Modulators $5 P $a modulátory tubulínu 686 $a D03.132.436.681.827.830 686 $a D03.633.100.473.402.681.827.830 686 $a D03.633.100.496.500.500.681.827.830 750 $a Vindesine $8 eng 801 -0
$a US $b DNLM $c 19920424 801 -2
$a SK $b BA006 $c 20070706 980 $x M
Počet záznamov: 1